Physician profile
Tara Beth Mancl
NPI 1467655779
$2,516.09
in general payments reported to CMS, 2019-2025
12 companies · $2,194 in 2025
The $2,194 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.12 · 2020: $34.53 · 2021: $55.72 · 2022: $141 · 2023: $36.25 · 2025: $2,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,867 · Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,866.80 |
| Food and Beverage | $363.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,151.25 | 2025 | |
| Molli Surgical (US) INC | $106.34 | 2022 | |
| Smith+Nephew, INC. | $73.59 | 2019-2025 | Stravix Pl |
| Davol INC. | $26.09 | 2023 | Phasix Mesh |
| Medtronic, INC. | $26.04 | 2021-2022 | |
| Merit Medical Systems INC | $24.01 | 2025 | Savi Scout |
| Dilon Technologies, INC. | $23.54 | 2021 | |
| Biom'Up France Sas | $22.94 | 2020 | |
| Merck Sharp & Dohme LLC | $22.06 | 2022 | |
| Heron Therapeutics, INC. | $18.48 | 2021 | |
| Integra Lifesciences Corporation | $11.59 | 2020 | |
| Lifenet Health | $10.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Mancl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.